Bank of New York Mellon Corp - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 62 filers reported holding VOR BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$229,403
-31.4%
108,2090.0%0.00%
Q2 2023$334,366
+407.6%
108,209
+783.7%
0.00%
Q1 2023$65,878
-19.1%
12,2450.0%0.00%
Q4 2022$81,429
-75.7%
12,245
-77.9%
0.00%
Q1 2022$335,000
-49.4%
55,375
-2.7%
0.00%
Q4 2021$662,000
-19.2%
56,930
+9.0%
0.00%
Q3 2021$819,000
+29.4%
52,251
+53.8%
0.00%
Q2 2021$633,000
-51.3%
33,963
+12.7%
0.00%
Q1 2021$1,300,00030,1410.00%
Other shareholders
VOR BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,361,723$34,226,0708.75%
OUP Management Co., LLC 374,714$2,015,9614.02%
Paradigm Biocapital Advisors LP 6,477,999$34,851,6353.30%
RA Capital Management 22,748,880$122,388,9742.77%
JOHNSON & JOHNSON 1,074,658$5,781,6601.88%
Artal Group S.A. 2,792,805$15,0250.89%
Trustees of Columbia University in the City of New York 91,910$494,4760.88%
Sarissa Capital Management LP 618,000$3,324,8400.42%
Laurion Capital Management LP 3,182,889$17,123,9430.12%
Woodline Partners LP 1,111,123$5,977,8420.08%
View complete list of VOR BIOPHARMA INC shareholders